Kirin Holdings Co. (OTCMKTS:KNBWY) Short Interest Update

Kirin Holdings Co. (OTCMKTS:KNBWY – Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totaling 28,981 shares, a decrease of 62.7% from the August 15th total of 77,766 shares. Based on an average daily trading volume, of 25,911 shares, the short-interest ratio is presently 1.1 days. Approximately 0.0% of the shares of the company are sold short.

Analyst Ratings Changes

Separately, Zacks Research lowered Kirin from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Get Kirin alerts:

View Our Latest Analysis on KNBWY

Kirin Stock Performance

Shares of Kirin stock traded up $0.16 during trading hours on Friday, hitting $18.17. 47,382 shares of the company were exchanged, compared to its average volume of 17,226. The company has a current ratio of 1.44, a quick ratio of 1.01 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average of $18.54 and a 200-day moving average of $17.25. Kirin has a 1 year low of $14.01 and a 1 year high of $19.99. The stock has a market capitalization of $14.72 billion, a price-to-earnings ratio of 11.57 and a beta of -0.01.

Kirin (OTCMKTS:KNBWY – Get Free Report) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.16. The firm had revenue of $4.08 billion for the quarter, compared to analyst estimates of $3.87 billion. Kirin had a net margin of 7.79% and a return on equity of 12.29%. As a group, analysts expect that Kirin will post 1.34 EPS for the current fiscal year.

About Kirin

(Get Free Report)

Kirin Holdings Company, Limited is a Japan-based company with businesses spanning alcoholic and nonalcoholic beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks, bottled water and other consumer products marketed under brands such as Kirin, Ichiban Shibori and Afternoon Tea.

The company’s pharmaceutical business is conducted primarily through Kyowa Kirin, which researches, develops and commercializes prescription medicines, including treatments in areas such as oncology, immunology and nephrology.

See Also

• Five stocks we like better than Kirin
• Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
• 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
• Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
• As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits

Receive News & Ratings for Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kirin and related companies with MarketBeat.com's FREE daily email newsletter.